Product Code: GVR-4-68040-275-9
Aesthetic Injectable Market Growth & Trends:
The global aesthetic injectable market size is expected to reach USD 24.13 billion by 2030, registering a CAGR of 12.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The industry is experiencing notable growth driven by several factors. These include increasing consumer awareness about minimally invasive cosmetic procedures, advancements in injectable technologies, and rising demand for non-surgical aesthetic enhancements.
Technological and research progress has led to the development of inventive injectable formulations, expanding the market's offerings to include various products addressing precise concerns like fine lines, wrinkles, volume loss, and skin texture. For instance, according to the National Center for Biotechnology and Information (NCBI) in January 2024, the injectable Sculptra Poly-L-Lactic Acid (PLLA-SCA) treatments were well received and notably diminished the severity of moderate to severe wrinkles and cheek lines while enhancing skin quality. Their effectiveness remained consistent throughout the 12-month study, with subjects reporting high satisfaction, achieving a natural appearance, and expressing eagerness for further treatments.
Additionally, shifting beauty standards and a growing aging population contribute to market expansion. Moreover, the availability of a wide range of injectable products, coupled with innovative marketing strategies by key players, further stimulates market growth. Furthermore, favorable regulatory frameworks and an expanding network of aesthetic clinics and medical spas are fostering the uptake of aesthetic injectables worldwide.
Aesthetic Injectable Market Report Highlights:
- Based on the product, the botulinum toxin (Botox) segment accounted for the largest revenue share of 45.8% in 2023 as it is used temporarily to reduce the appearance of facial wrinkles and fine lines
- The hyaluronic acid (HA) segment is expected to grow at the fastest CAGR of 12.7% during the forecast period as it provides the advantage of enhancing skin hydration, volume, and elasticity, resulting in a smoother and more youthful appearance
- Based on the end-use, the medical spas segment accounted for the largest revenue share of 46.9% in 2023 and is expected to grow at the fastest CAGR of 12.3% during the forecast period. Medical spas contribute to the growth of the aesthetic injectables market by offering a range of cosmetic procedures, including injectable treatments, in a relaxing and luxurious environment
- Based on the application, the facial line correction segment accounted for the largest revenue share of 33.4% in 2023 and is expected to grow at the fastest CAGR of 12.5% during the forecast period, as it addresses various concerns such as fine lines, wrinkles, and volume loss for facial rejuvenation
- In 2023, North America dominated with a share of 39.3% due to the constant demand for cosmetic enhancement products and Asia Pacific is expected to grow at the fastest CAGR of 15.8% during the forecast period as this region is a hub for technological innovation, with continuous advancements in aesthetic injectables and techniques
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. End use
- 1.2.3. Application
- 1.2.4. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. End use outlook
- 2.2.3. Application outlook
- 2.3. Competitive Insights
Chapter 3. Aesthetic Injectable Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver Analysis
- 3.2.2. Market restraint analysis
- 3.3. Aesthetic Injectable Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. Aesthetic Injectable Market: Product Estimates & Trend Analysis
- 4.1. Product Market Share, 2023 & 2030
- 4.2. Segment Dashboard
- 4.3. Aesthetic Injectable Market by Product Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.4.1. Hyaluronic Acid (HA)
- 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2. Botulinum Toxin (Botox)
- 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3. Aquatic Light Injections
- 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.4. Others
- 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Aesthetic Injectable Market: End Use Estimates & Trend Analysis
- 5.1. End Use Market Share, 2023 & 2030
- 5.2. Segment Dashboard
- 5.3. Aesthetic Injectable Market by End Use Outlook
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.4.1. Medical Spas
- 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2. Dermatology Clinics
- 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3. Hospitals
- 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Aesthetic Injectable Market: Application Estimates & Trend Analysis
- 6.1. Application Market Share, 2023 & 2030
- 6.2. Segment Dashboard
- 6.3. Aesthetic Injectable Market by Application Outlook
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.4.1. Facial Line Correction
- 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.2. Lip Augmentation
- 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.3. Face Lift
- 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.4. Acne Scar Treatment
- 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.5. Lipoatrophy Treatment
- 6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.6. Others
- 6.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Company/Competition Categorization
- 7.2. Company Profiles
- 7.2.1. Ipsen Pharma
- 7.2.1.1. Company overview
- 7.2.1.2. Financial performance
- 7.2.1.3. Product benchmarking
- 7.2.1.4. Strategic initiatives
- 7.2.2. AbbVie, Inc.
- 7.2.2.1. Company overview
- 7.2.2.2. Financial performance
- 7.2.2.3. Product benchmarking
- 7.2.2.4. Strategic initiatives
- 7.2.3. Merz GmbH and Co. KGaA
- 7.2.3.1. Company overview
- 7.2.3.2. Financial performance
- 7.2.3.3. Product benchmarking
- 7.2.3.4. Strategic initiatives
- 7.2.4. Galderma
- 7.2.4.1. Company overview
- 7.2.4.2. Financial performance
- 7.2.4.3. Product benchmarking
- 7.2.4.4. Strategic initiatives
- 7.2.5. Prollenium Medical Technologies, Inc.
- 7.2.5.1. Company overview
- 7.2.5.2. Financial performance
- 7.2.5.3. Product benchmarking
- 7.2.5.4. Strategic initiatives
- 7.2.6. Suneva Medical, Inc.
- 7.2.6.1. Company overview
- 7.2.6.2. Financial performance
- 7.2.6.3. Product benchmarking
- 7.2.6.4. Strategic initiatives
- 7.2.7. Sinclair Pharma
- 7.2.7.1. Company overview
- 7.2.7.2. Financial performance
- 7.2.7.3. Product benchmarking
- 7.2.7.4. Strategic initiatives
- 7.2.8. Medytox, Inc.
- 7.2.8.1. Company overview
- 7.2.8.2. Financial performance
- 7.2.8.3. Product benchmarking
- 7.2.8.4. Strategic initiatives
- 7.2.9. Revance Therapeutics, Inc.
- 7.2.9.1. Company overview
- 7.2.9.2. Financial performance
- 7.2.9.3. Product benchmarking
- 7.2.9.4. Strategic initiatives